A multicenter team including Endeavor Health and Eli Lilly found that once-weekly eloralintide produced dose-dependent weight loss up to 20% over 48 weeks in adults with obesity or overweight without ...
A small study suggests every-other-week GLP-1 shots could be enough for locking in weight loss — but there are caveats. In a small new study, most people who switched from weekly to every-other-week ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results